CVE-2022-29939
MEDIUMCVSS 5.4/10EPSS 0.82%
Last modified
CVE-2022-29939 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. In LibreHealth EHR 2.0.0, lack of sanitization of the GET parameters debug and InsId in interface\billing\sl_eob_process.php leads to multiple cross-site scripting (XSS) vulnerabilities.. EPSS estimates a 0.82% chance of exploitation in the next 30 days.
Description
In LibreHealth EHR 2.0.0, lack of sanitization of the GET parameters debug and InsId in interface\billing\sl_eob_process.php leads to multiple cross-site scripting (XSS) vulnerabilities.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Librehealth | Librehealth Ehr | 2.0.0 |
References
- https://github.com/LibreHealthIO/lh-ehr/tagsThird Party Advisory
- https://gitlab.com/librehealth/ehr/lh-ehr/-/tagsThird Party Advisory
- https://nitroteam.kz/index.php?action=researches&slug=librehealth_rExploit, Third Party Advisory
- https://github.com/LibreHealthIO/lh-ehr/tagsThird Party Advisory
- https://gitlab.com/librehealth/ehr/lh-ehr/-/tagsThird Party Advisory
- https://nitroteam.kz/index.php?action=researches&slug=librehealth_rExploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-29939?
In LibreHealth EHR 2.0.0, lack of sanitization of the GET parameters debug and InsId in interface\billing\sl_eob_process.php leads to multiple cross-site scripting (XSS) vulnerabilities.
How severe is CVE-2022-29939?
CVE-2022-29939 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.82% probability of exploitation in the next 30 days.
How do I fix CVE-2022-29939?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-29939?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
